Healthcare Health/Fitness

Pfizer and AstraZeneca have announced massive investments in France totaling nearly $1 billion.

The closure of Walmart's health centers will make healthcare access difficult for rural and low-income Americans, particularly in Arkansas, Florida, Georgia, Illinois, and Texas...

Over 200 individuals have suffered injuries due to a glitch in a popular iPhone app and its corresponding insulin pump...

Major healthcare nonprofit Ascension said a cyberattack had interrupted its "clinical operations," prompting it to take measures to limit any impact on patient care...

The Center for Medicare and Medicaid Services (CMS) is the single larg...

Elon Musk's brain implant company, Neuralink, reported a malfunction i...

Latest News

Change Healthcare, a subsidiary of US health insurance giant UnitedHealth Group (UHG), was possibly breached by hackers backed by a government, according to a filing with government regulators.

South Korea has ordered thousands of protesting physicians to return to work immediately.

The US Food and Drug Administration (FDA) has approved a new drug called Xolair that could be life-changing for those with severe food allergies.

A new study that examined the genetic code of nearly 250,000 volunteers in the US found over 275 million entirely new variants.

North Korea is making efforts to expand its Koryo medicine production.

Pfizer has agreed to pay $93 million to resolve antitrust claims by wholesale drug distributors accusing the pharmaceutical giant of conspiring with India's Ranbaxy Laboratories to delay the sales of

Russia's President Vladimir Putin announced on Wednesday that Russian scientists are on the verge of developing vaccines for cancer, which could soon be available to patients.

Genetic testing and biotechnology company 23andMe is facing numerous challenges, including more than 30 lawsuits.

Elon Musk's brain implant company, Neuralink, has changed the location of its business incorporation from Delaware to Nevada.

A division of French ad firm Publicis Groupe SA and drugmaker Hikma Pharmaceuticals have reached separate settlements totaling $500 million to resolve allegations that they helped fuel the deadly opio